| pubmed-article:15375494 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15375494 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:15375494 | lifeskim:mentions | umls-concept:C0024204 | lld:lifeskim |
| pubmed-article:15375494 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:15375494 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:15375494 | lifeskim:mentions | umls-concept:C0441766 | lld:lifeskim |
| pubmed-article:15375494 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15375494 | pubmed:dateCreated | 2004-9-17 | lld:pubmed |
| pubmed-article:15375494 | pubmed:abstractText | Prediction of the recurrence of primary breast cancer was attempted by detection of occult neoplastic cells (ONCs) in lymph nodes or by using the high-risk criteria for recurrence/metastasis of gastric and colorectal cancer. The subjects were 70 patients with stage I or II node-negative primary breast cancer. Prediction of recurrence using ONCs had a sensitivity of 60.0% (3/5) and a false-negative rate of 40.0% (2/5) in the recurrence group, while the specificity was 96.9% (63/65) and the false-positive rate was 3.1% (2/65) in the non-recurrence group. The accuracy of ONCs was 78.5%. Prediction of recurrence based on positivity for at least 2 of the high-risk criteria showed a sensitivity of 60.0% (3/5) and a false-negative rate of 40.0% (2/5) in the recurrence group, while the specificity was 95.4% (62/65) and the false-positive rate was 4.6% (3/65) in the non-recurrence group. The accuracy of the high-risk criteria was 77.7%. These results suggest that ONCs show the same accuracy as the high-risk criteria for predicting recurrence/metastasis of stage I and II node-negative breast cancer with a high specificity. | lld:pubmed |
| pubmed-article:15375494 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15375494 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15375494 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15375494 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15375494 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:15375494 | pubmed:issn | 1021-335X | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:MukaiMasayaM | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:MakuuchiHiroy... | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:KomatsuNobuka... | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:NakasakiHisao... | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:SatoShinkichi... | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:KimuraTomomiT | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:OgoshiKyoujiK | lld:pubmed |
| pubmed-article:15375494 | pubmed:author | pubmed-author:NinomiyaHirom... | lld:pubmed |
| pubmed-article:15375494 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15375494 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:15375494 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15375494 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15375494 | pubmed:pagination | 745-8 | lld:pubmed |
| pubmed-article:15375494 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:meshHeading | pubmed-meshheading:15375494... | lld:pubmed |
| pubmed-article:15375494 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15375494 | pubmed:articleTitle | Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis. | lld:pubmed |
| pubmed-article:15375494 | pubmed:affiliation | Department of Surgery, Tokai University Oiso Hospital, Kanagawa 259-0198, Japan. onc-res@oiso.u-tokai.ac.jp onc-res@oiso.u-tokai.ac.jp | lld:pubmed |
| pubmed-article:15375494 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15375494 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
